JP2005511547A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511547A5
JP2005511547A5 JP2003538145A JP2003538145A JP2005511547A5 JP 2005511547 A5 JP2005511547 A5 JP 2005511547A5 JP 2003538145 A JP2003538145 A JP 2003538145A JP 2003538145 A JP2003538145 A JP 2003538145A JP 2005511547 A5 JP2005511547 A5 JP 2005511547A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
compound according
alkoxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003538145A
Other languages
English (en)
Japanese (ja)
Other versions
JP4464681B2 (ja
JP2005511547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/031568 external-priority patent/WO2003035629A1/en
Publication of JP2005511547A publication Critical patent/JP2005511547A/ja
Publication of JP2005511547A5 publication Critical patent/JP2005511547A5/ja
Application granted granted Critical
Publication of JP4464681B2 publication Critical patent/JP4464681B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003538145A 2001-10-25 2002-10-15 抗腫瘍薬としてのチオペン−およびチアゾール−スルホンアミド Expired - Fee Related JP4464681B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35201201P 2001-10-25 2001-10-25
PCT/US2002/031568 WO2003035629A1 (en) 2001-10-25 2002-10-15 Thiopene- amd thiazolesulfonamides as antineoplastic agents

Publications (3)

Publication Number Publication Date
JP2005511547A JP2005511547A (ja) 2005-04-28
JP2005511547A5 true JP2005511547A5 (enExample) 2006-01-05
JP4464681B2 JP4464681B2 (ja) 2010-05-19

Family

ID=23383421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003538145A Expired - Fee Related JP4464681B2 (ja) 2001-10-25 2002-10-15 抗腫瘍薬としてのチオペン−およびチアゾール−スルホンアミド

Country Status (33)

Country Link
US (2) US7084170B2 (enExample)
EP (1) EP1442030B1 (enExample)
JP (1) JP4464681B2 (enExample)
KR (1) KR100913471B1 (enExample)
CN (1) CN1298709C (enExample)
AR (1) AR037248A1 (enExample)
AT (1) ATE338033T1 (enExample)
AU (1) AU2002334817B2 (enExample)
BR (1) BR0212386A (enExample)
CA (1) CA2463300C (enExample)
CY (1) CY1106247T1 (enExample)
DE (1) DE60214413T2 (enExample)
DK (1) DK1442030T3 (enExample)
EA (1) EA006081B1 (enExample)
EC (1) ECSP045078A (enExample)
EG (1) EG26021A (enExample)
ES (1) ES2269816T3 (enExample)
HR (1) HRP20040371B1 (enExample)
HU (1) HUP0401638A3 (enExample)
IL (2) IL160851A0 (enExample)
MX (1) MXPA04003886A (enExample)
MY (1) MY130718A (enExample)
NO (1) NO20041316L (enExample)
NZ (1) NZ531136A (enExample)
PE (1) PE20030574A1 (enExample)
PL (1) PL208083B1 (enExample)
PT (1) PT1442030E (enExample)
SI (1) SI1442030T1 (enExample)
SV (1) SV2004001367A (enExample)
TW (1) TWI281916B (enExample)
UA (1) UA75716C2 (enExample)
WO (1) WO2003035629A1 (enExample)
ZA (1) ZA200403089B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1401825E (pt) * 2001-06-11 2009-10-23 Virochem Pharma Inc Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
US7375131B2 (en) * 2002-06-06 2008-05-20 Smithklinebeecham Corp. NF-κB inhibitors
CN100413861C (zh) 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
SE0300092D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) * 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006030947A1 (ja) * 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
WO2006090921A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. スルホンアミド化合物のリンパ球活性化抑制作用
KR20070114774A (ko) * 2005-02-28 2007-12-04 에자이 알앤드디 매니지먼트 가부시키가이샤 술폰아미드 화합물의 혈관 신생 저해 물질과의 신규 병용
DE602006021401D1 (de) 2005-02-28 2011-06-01 Eisai R&D Man Co Ltd Neue kombinierte anwendung einer sulfonamid-verbindung zur behandlung von krebs
NZ563909A (en) 2005-05-13 2011-10-28 Virochem Pharma Inc Thiophene derivatives and their use for the treatment or prevention of flavivirus infections
US7208506B2 (en) 2005-07-07 2007-04-24 Hoffmann-La Roche Inc. Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
US7625896B2 (en) * 2005-11-25 2009-12-01 Hoffman-La Roche Inc. Pyridylsulfonamide derivatives
JPWO2007123274A1 (ja) 2006-04-20 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド化合物の新規感受性マーカー
US7939532B2 (en) * 2006-10-26 2011-05-10 Hoffmann-La Roche Inc. Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
CA2670260A1 (en) 2006-11-15 2008-05-22 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of flavivirus infections
US7879884B2 (en) 2007-05-16 2011-02-01 Hoffmann-La Roche Inc. Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
CN101899008B (zh) * 2010-05-20 2012-10-17 中国人民解放军第二军医大学 N-取代嘧啶磺酰基-取代苯甲酰胺类化合物及其制备药物的用途
CN103450149B (zh) * 2012-06-01 2015-10-14 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物及其制备方法和用途
JP6364967B2 (ja) * 2014-05-30 2018-08-01 東ソー株式会社 ジチエノベンゾジチオフェンの製造方法
CN106588868A (zh) * 2016-11-16 2017-04-26 武汉理工大学 一种2‑溴‑3‑噻吩甲酸中间体的合成方法
CN108558822B (zh) * 2018-06-01 2020-12-18 盐城锦明药业有限公司 N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法
CN110835345A (zh) * 2018-08-17 2020-02-25 中国科学院上海药物研究所 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途
CN109265437A (zh) * 2018-10-19 2019-01-25 凯莱英医药集团(天津)股份有限公司 一种3-羟基噻吩-2-羧酸酯类化合物的制备方法
WO2024251876A1 (en) * 2023-06-07 2024-12-12 KRæFTENS BEKæMPELSE PROTACs AND HyT-PD MOLECULES FOR TARGETED PROTEIN DEGRADATION OF DCAF15 AND THEIR USE IN THE TREATMENT OF AMYLOIDOSIS
WO2025031360A1 (zh) * 2023-08-09 2025-02-13 上海科技大学 磺酰胺类化合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA813332B (en) * 1980-06-21 1982-05-26 Pfizer Larvicides and isecticides
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
AU737038B2 (en) * 1996-07-05 2001-08-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
CA2267998A1 (en) * 1996-10-04 1998-04-09 Eli Lilly And Company Antitumor compositions and methods of treatment
JP4316787B2 (ja) 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、

Similar Documents

Publication Publication Date Title
JP2005511547A5 (enExample)
JP2003520195A5 (enExample)
JP2006509749A5 (enExample)
JP2007510619A5 (enExample)
JP2001526218A5 (enExample)
JP2005522421A5 (enExample)
JP2008523126A5 (enExample)
CA2463300A1 (en) Thiopene- and thiazolesulfonamides as antineoplastic agents
JP2005526144A5 (enExample)
JP2004519469A5 (enExample)
JP2004532209A5 (enExample)
JP2003531118A5 (enExample)
JP2003509349A5 (enExample)
JP2013508279A5 (enExample)
RU96115142A (ru) Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов
JP2005053931A5 (enExample)
JP2007520440A5 (enExample)
RU2005104104A (ru) Производные амида коричной кислоты
JP2003503449A5 (enExample)
JP2007502817A5 (enExample)
JP2006504738A5 (enExample)
RU2005121908A (ru) Производные зн-хиназолин-4-она
JP2005511602A5 (enExample)
JP2005522492A5 (enExample)
JP2004525178A5 (enExample)